天山股份(000877.SZ):擬吸收合併全資子公司新疆屯河水泥
格隆匯 3 月 31日丨天山股份(000877.SZ)公佈,公司於2021年3月31日召開的第七屆董事會第三十五次會議,以7票同意,0票反對,0票棄權,審議通過了《新疆天山水泥股份有限公司關於吸收合併全資子公司的議案》,同意公司吸收合併全資子公司新疆屯河水泥有限責任公司(“屯河水泥”)。
根據公司整體發展及目前經營情況的需要,公司吸收合併屯河水泥後,屯河水泥獨立法人資格將被註銷,資產及其持有的其他法人股權歸屬本公司,礦山將根據所在地相關管理規定設立分公司管理礦山事宜,同意並授權本公司經營層負責辦理具體事宜,包括但不限於協議的簽署、辦理相關資產的轉移、工商變更登記及設立分公司等事宜。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.